Company Overview
About AOA DX
AOA DX is a company based in Denver, Colorado, that is pioneering the field of lipidomics for early cancer detection, particularly in women's health. The company's revolutionary multi-omics platform, GlycoLocate™, and its AI-enabled early detection technology, Akrivis GD™, aim to provide life-saving early cancer detection capabilities through the utilization of tumor marker gangliosides and other complementary biomarkers.
Technologies Used
Key Decision Makers
| Name | Job Title | Contact | |
|---|---|---|---|
Lindsey Kemp | Senior Clinical Trial Associate | LinkedIn Profile | |
Michael Matthews | Senior Clinical Trial Specialist | LinkedIn Profile | |
Savannah Harris | Clinical Trial Associate | LinkedIn Profile |